Definium Therapeutics, Inc.

DFTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K May 27, 2025 FORM 8-K
SCHEDULE 13G/A May 15, 2025
10-Q May 8, 2025 10-Q
8-K May 8, 2025 8-K
D May 5, 2025
ARS Apr 23, 2025 ARS
DEFA14A Apr 23, 2025 DEFA14A
DEF 14A Apr 23, 2025 DEF 14A
8-K Apr 21, 2025 FORM 8-K
8-K Apr 15, 2025 8-K
4 Mar 26, 2025 4
4 Mar 26, 2025 4
4 Mar 26, 2025 4
4 Mar 26, 2025 4
144 Mar 25, 2025
144 Mar 25, 2025
144 Mar 25, 2025
144 Mar 25, 2025
4 Mar 18, 2025 4
3 Mar 18, 2025 3
4 Mar 13, 2025 4
4 Mar 13, 2025 4
4 Mar 13, 2025 4
4 Mar 13, 2025 4
10-K Mar 6, 2025 10-K
← Newer Page 6 of 21 · 504 filings Older →